The transforming growth factor-β (TGF-β) pathway exerts contrasting roles in OC pathogenesis, serving as a tumor suppressor in the initial stages of the disease while promoting processes such as epithelial-to-mesenchymal transition (EMT) and immune evasion during advanced metastatic progression [13]. Here, TGFB1 is linked to neoplasm.